Legal Image FR Corporate / 10.05.2024 THE ORDINARY GENERAL MEETING 2024 OF IBA SA - WEDNESDAY, JUNE 12, 2024 - POSTAL VOTING FORM Read more THE ORDINARY GENERAL MEETING 2024 OF IBA SA - WEDNESDAY, JUNE 12, 2024 - POSTAL VOTING FORM
Press releases Image FR EN Proton Therapy / 02.05.2024 IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US Read more IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US
Press releases Image EN FR Corporate / 11.04.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Corporate / 21.03.2024 IBA Reports Full Year 2023 Results Read more IBA Reports Full Year 2023 Results
Press releases Image EN FR Industrial Solutions / 19.03.2024 IBA signs contract to install a Be-Efficient irradiation solution in Germany Read more IBA signs contract to install a Be-Efficient irradiation solution in Germany
Press releases Image EN Corporate / 14.03.2024 PanTera signs a second agreement for the supply of actinium-225 Read more PanTera signs a second agreement for the supply of actinium-225
Press releases Image EN FR RadioPharma Solutions / 29.02.2024 IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa Read more IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa
Press releases Image EN FR Corporate / 26.02.2024 IBA Notice of Full Year 2023 Results and Conference Call Read more IBA Notice of Full Year 2023 Results and Conference Call
Press releases Image EN FR Corporate / 20.02.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN Corporate / 13.02.2024 PanTera signs agreement with Bayer for the supply of actinium-225 Read more PanTera signs agreement with Bayer for the supply of actinium-225
Press releases Image EN FR Corporate / 08.02.2024 IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence Read more IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence
Press releases Image FR EN Corporate / 05.02.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Corporate / 01.02.2024 IBA launches Oncia Community, a public utility foundation, dedicated to humanizing cancer care. Read more IBA launches Oncia Community, a public utility foundation, dedicated to humanizing cancer care.
Press releases Image FR EN Corporate / 31.01.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR RadioPharma Solutions / 23.01.2024 iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70 Read more iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70
Press releases Image FR EN Corporate / 09.01.2024 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Proton Therapy / 21.12.2023 IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center Read more IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center
Press releases Image EN FR RadioPharma Solutions / 20.12.2023 IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron Read more IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron
Press releases Image EN FR RadioPharma Solutions / 13.12.2023 IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease Read more IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
Press releases Image EN FR RadioPharma Solutions / 12.12.2023 IBA pioneers theranostic advancements, empowering the market to produce Astatine-211 Read more IBA pioneers theranostic advancements, empowering the market to produce Astatine-211
